FDA rejects Pacira's application for expanded use of pain drug

March 2, 2015 11:55 AM

4 0

FDA rejects Pacira's application for expanded use of pain drug

(Reuters) - The U.S. Food and Drug Administration rejected Pacira Pharmaceuticals Inc's application for expanding the use of its post-surgery pain drug, Exparel.

Exparel is currently injected into the site of an operation to manage pain after surgery and Pacira sought to use the drug as a nerve numbing injection for cases where it is difficult to inject a painkiller directly into the affected area.

Also read: Belgian police help break major drug, money laundering ring

Read more

To category page

Loading...